TARGET.: Gene Therapy for the treatment of diabetic retinopathy (Q2878607): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en, pt: Fixing missing labels.) |
(Removed claim: co-financing rate (P837): 40.0 percentage) |
||||||
Property / co-financing rate | |||||||
| |||||||
Property / co-financing rate: 40.0 percent / rank | |||||||
Revision as of 17:50, 4 November 2022
Project Q2878607 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | TARGET.: Gene Therapy for the treatment of diabetic retinopathy |
Project Q2878607 in Portugal |
Statements
95,820.0 Euro
0 references
239,549.0 Euro
0 references
1 September 2018
0 references
31 August 2021
0 references
UNIVERSIDADE NOVA DE LISBOA
0 references
Q2993197 (Deleted Item)
0 references
Lisboa
0 references
Identifiers
LISBOA-01-0145-FEDER-028121
0 references